Osteosarcoma

Osteosarcoma

Osteosarcoma is an aggressive bone cancer primarily affecting adolescents and young adults.

CureU Healthcare offers advanced diagnosis and tailored therapies for better functional outcomes.

Overview And Clinical Background

Osteosarcoma develops in long bones, often near the knee or shoulder.

Early detection is key to preventing metastasis.

Key point:Most common primary bone malignancy in youth.

Caused by abnormal bone growth and rapid cellular division.

Third point:Multimodal treatment improves survival rates.

Symptoms include localized pain, swelling, or limited movement.

Fractures may occur spontaneously in weakened bone.

Common symptom:Persistent bone pain, especially at night.

Swelling or visible lump at the tumor site.

Red flag:Sudden fracture with minimal trauma.

Diagnosis involves imaging, biopsy, and staging.

Early identification allows limb-preserving surgery.

Imaging:X-rays, MRI, and bone scans to assess tumor size.

Lab tests:Alkaline phosphatase and LDH may be elevated.

Biopsy confirms cell type and malignancy grade.

Treatment combines surgery, chemotherapy, and sometimes radiation.

CureU Healthcare focuses on functional limb preservation.

Conservative:Pain management and physiotherapy in inoperable cases.

Minimally invasive options:Targeted chemotherapy before surgery to shrink tumor.

Limb-salvage surgery or prosthetic reconstruction post-resection.

Recovery requires rehabilitation for mobility and muscle strength.

Early intervention significantly improves survival odds.

Our multidisciplinary oncology team ensures effective Osteosarcoma care using cutting-edge surgical and chemotherapeutic approaches.

CureU Healthcare helps restore hope and mobility with expertise in advanced bone cancer care.